sumatriptan has been researched along with frovatriptan in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 17 (65.38) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Adham, N; Audia, JE; Kohlman, DT; Krushinski, J; Liang, SX; Schaus, JM; Walker, C; Xu, YC; Zgombick, JM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Dücker, C; Gebauer, L; Jensen, O | 1 |
| Campbell, CA; Griffiths, R; Hamilton, TC; Hunter, AJ; King, FD; Lewis, VA; Parker, SG; Parsons, AA; Raval, P | 1 |
| Hunter, J; Kaumann, AJ; King, FD; Parsons, AA; Raval, P; Smith, S; Tilford, N | 1 |
| Berdeaux, A; Carel, I; Dubois-Rande, JL; Edouard, A; Ghaleh, B; Giudicelli, JF; Parsons, AA | 1 |
| Marcus, DA | 1 |
| Rapoport, AM; Tepper, SJ | 1 |
| Freitag, FG | 1 |
| Comer, MB | 1 |
| Géraud, G; Keywood, C; Spierings, EL | 1 |
| Rapoport, AM; Sheftell, FD; Tepper, SJ | 1 |
| Csiba, L; Ficzere, A | 1 |
| Adelman, JU; Lewit, EJ | 1 |
| Steiner, T; Tfelt-Hansen, P | 1 |
| Jähnichen, S; Pertz, HH; Radtke, OA | 1 |
| Balbisi, EA | 1 |
| Kowa, H; Nakashima, K; Takeshima, T | 1 |
| Davenport, WJ; Dodick, D; Pringsheim, T | 1 |
| Tfelt-Hansen, P | 2 |
| Campbell, JC; Hu, X; MacGregor, EA; Pawsey, SP | 1 |
| Qi, JZ; Zhang, H; Zhang, ZH | 1 |
12 review(s) available for sumatriptan and frovatriptan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans).
Topics: Analgesics, Non-Narcotic; Carbazoles; Clinical Trials as Topic; Humans; Indoles; Migraine Disorders; Oxazolidinones; Pain Measurement; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Triptans are all different.
Topics: Carbazoles; Headache; Humans; Indoles; Oxazolidinones; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2001 |
Acute treatment of migraine and the role of triptans.
Topics: Acute Disease; Blood Flow Velocity; Carbazoles; Clinical Trials as Topic; Drug Administration Routes; Female; Humans; Indoles; Male; Menstruation; Migraine Disorders; Oxazolidinones; Piperidines; Practice Guidelines as Topic; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Mechanisms of action of the 5-HT1B/1D receptor agonists.
Topics: Carbazoles; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2002 |
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
Comparative aspects of triptans in treating migraine.
Topics: Carbazoles; Cardiovascular Diseases; Humans; Indoles; Migraine Disorders; Oxazolidinones; Patient Satisfaction; Piperidines; Pyrrolidines; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2001 |
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
Topics: Carbazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2004 |
[Meta-analysis of triptan treatment in migraine].
Topics: Carbazoles; Evidence-Based Medicine; Humans; Indoles; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
Acute treatment and prevention of menstrually related migraine headache: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Double-Blind Method; Estrogens; Evidence-Based Medicine; Female; Humans; Male; Mefenamic Acid; Menstruation; Meta-Analysis as Topic; Migraine Disorders; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines | 2008 |
Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
Topics: Acute Disease; Carbazoles; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Menstruation Disturbances; Migraine Disorders; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Research Design; Safety; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2010 |
Comparative efficacy of different treatments for menstrual migraine: a systematic review and network meta-analysis.
Topics: Humans; Migraine Disorders; Network Meta-Analysis; Sumatriptan; Tryptamines | 2023 |
1 trial(s) available for sumatriptan and frovatriptan
| Article | Year |
|---|---|
Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
Topics: Acute Disease; Adult; Carbazoles; Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Fatigue; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Paresthesia; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2002 |
13 other study(ies) available for sumatriptan and frovatriptan
| Article | Year |
|---|---|
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist.
Topics: Cell Line; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Radioligand Assay; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship; Tryptamines | 1999 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Substrates and Inhibitors of the Organic Cation Transporter 3 and Comparison with OCT1 and OCT2.
Topics: Biological Transport; Cations; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2 | 2022 |
Comparison of the cardiovascular effects of the novel 5-HT(1B/1D) receptor agonist, SB 209509 (VML251), and sumatriptan in dogs.
Topics: Animals; Biological Availability; Blood Pressure; Carbazoles; Cardiovascular System; Carotid Arteries; Coronary Circulation; Coronary Vessels; Dogs; Duodenum; Female; Heart Rate; Infusions, Intravenous; Male; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Regional Blood Flow; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vascular Resistance | 1997 |
Effects of the novel high-affinity 5-HT(1B/1D)-receptor ligand frovatriptan in human isolated basilar and coronary arteries.
Topics: Basilar Artery; Carbazoles; Coronary Circulation; Humans; In Vitro Techniques; Ligands; Muscle Contraction; Muscle, Smooth; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 1998 |
Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs.
Topics: Animals; Carbazoles; Carotid Artery, Internal; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vascular Resistance; Vasoconstriction; Vasodilation | 2001 |
Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan.
Topics: Animals; Carbazoles; Cerebrovascular Circulation; Guinea Pigs; Humans; In Vitro Techniques; Rabbits; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines; Vasoconstrictor Agents | 2002 |
The truth about frovatriptan.
Topics: Carbazoles; Clinical Trials as Topic; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2003 |
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery.
Topics: Animals; Benzamides; Brain; Carbazoles; Dinoprost; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Forecasting; Guinea Pigs; Iliac Artery; Indoles; Ketanserin; Male; Muscle Contraction; Muscle, Smooth; Oxadiazoles; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Sumatriptan; Triazoles; Tryptamines | 2004 |
Frovatriptan and data publication.
Topics: Carbazoles; Double-Blind Method; Humans; Migraine Disorders; Periodicals as Topic; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 2008 |
Effective symptomatic medication should be available in prophylactic trials in cluster headache.
Topics: Carbazoles; Cluster Headache; Guidelines as Topic; Humans; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists; Sumatriptan; Treatment Outcome; Tryptamines | 2011 |